in.bio.motion
Biotechnology ResearchView the employees at
in.bio.motion-
Jon Askaa Non-executive Director at Inbiomotion SL
-
Copenhagen, Capital Region, Denmark
-
Top 5%
David L. Lacey Biopharmaceutical Consultant-
Cambria, California, United States
-
Rising Star
-
Overview
We provide a test that generates objective insights into whether a patient has above-normal levels of the MAF gene. In doing so, we enable pathologists with a new tool for oncologists expanding their possibilities to treat patients effectively and efficiently with bisphosphonates while minimising the possible risk of a relapse in the future. Our dedication and drive to generate clinical results, offers a new proven perspective that will progress precision medicine today.